|1.||Shephard, Adrian: 4 articles (11/2015 - 01/2011)|
|2.||Field, Emma: 2 articles (06/2013 - 01/2012)|
|3.||Beschorner, Ulrich: 1 article (12/2015)|
|4.||Scheinert, Dierk: 1 article (12/2015)|
|5.||Schlüter, Michael: 1 article (12/2015)|
|6.||Kieback, Arne: 1 article (12/2015)|
|7.||Ingwersen, Maja: 1 article (12/2015)|
|8.||Krankenberg, Hans: 1 article (12/2015)|
|9.||Zeller, Thomas: 1 article (12/2015)|
|10.||Blessing, Erwin: 1 article (12/2015)|
|1.||Pharyngitis (Sore Throat)
01/01/2011 - "A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat."
05/01/2011 - "Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges."
01/01/2011 - "In this multicentre, randomised, double-blind, single-dose study, 225 adult patients with acute sore throat were randomly assigned to receive either one AMC/DCBA Warm lozenge (n = 77), one AMC/DCBA Cool lozenge (n = 74) or one unflavoured, non-medicated lozenge (matched for size, shape and demulcency; n = 74). "
01/01/2010 - "Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial."
01/01/2011 - "AMC/DCBA Warm and AMC/DCBA Cool lozenges are well-tolerated and effective OTC treatment options, offering functional, sensorial and emotional benefits to patients with acute sore throat, over and above that of the rapid efficacy effects provided. "
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
11/01/2015 - "These findings suggest that AMC/DCBA lozenge and hexylresorcinol lozenge have the potential to have local antiviral effects in patients with sore throat due to viral respiratory tract infections. "
01/01/2011 - "The aim of this study was to determine the analgesic and sensorial benefits of two different amylmetacresol/2,4-dichlorobenzyl alcohol (AMC/DCBA) throat lozenge formulation variants, AMC/DCBA Warm lozenge and AMC/DCBA Cool lozenge, compared with an unflavoured, non-medicated placebo lozenge in the relief of acute sore throat due to upper respiratory tract infections. "
01/01/2010 - "This study was designed to determine the analgesic properties of amylmetacresol and 2,4-dichlorobenzyl alcohol (AMC/DCBA) throat lozenges (Strepsils) in the relief of acute sore throat caused by upper respiratory tract infections. "
01/01/2012 - "This study was conducted to determine the analgesic efficacy of two lozenges one containing amylmetacresol (AMC)/2,4-dichlorobenzyl alcohol (DCBA) and lidocaine and one containing hexylresorcinol versus placebo in patients with acute sore throat due to upper respiratory tract infection (URTI). "
01/01/2010 - "The superior analgesic effects and improvements in functional impairment scores observed with AMC/DCBA throat lozenges translate into pain relief benefits that are clinically meaningful and are thus a suitable OTC treatment option for patients in the self-management of acute sore throat."